INTERNATIONAL PATENT: TSCAN THERAPEUTICS, INC. FILES APPLICATION FOR "MAGEA1 IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING MAGEA1 IMMUNOGENIC PEPTIDES AND USES THEREOF"

GENEVA, May 6 -- TSCAN THERAPEUTICS, INC. (830 Winter StreetWaltham, MA 02451) filed a patent application (PCT/US2024/052934) for "MAGEA1 IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING MAGEA1 IMMUNOGENIC PEPTIDES, AND USES THEREOF" on Oct 25, 2024. With publication no. WO/2025/090850, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NABILSI, Nancy (c/o Tscan Therapeutics, Inc.830 Winter StreetWaltham, MA 02451), TADROS, Jenny (c/o Tscan Therapeutics, Inc.830 Winter StreetWaltham, MA 02451), JUREWICZ, Mollie, M. (c/o Ts...